Although the aligned pathway is central to our work, the benefits of improved collaboration between MHRA and NICE go beyond it. A recent example is aficamten, a new daily pill for people with ...
NICE HealthTech guidance evaluates digital technologies, diagnostics and medical devices (including artificial intelligence). It provides evidence-based recommendations about how safe and effective ...
Evidence-based recommendations on mirdametinib (Ezmekly) for treating symptomatic and inoperable plexiform neurofibromas associated with neurofibromatosis type 1 in people 2 to 17 years ...
Learn how NICE Advice’s system engagement service helps life sciences companies spot NHS adoption barriers before they become roadblocks.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results